Uncover the true value

  • Make stronger assumptions about future uptake with a 360-degree view of any patient population

  • Pinpoint relevant patients, unlike other solutions that offer simple sizing of an entire diseased population

  • Better inform pricing assumptions with a dataset that covers all 50 states and payer types, and can be sliced and diced in real-time

  • More precisely predict the future cost of sales with analytics that can identify the treating NPI and site for each claim

Resources

Case Study

QED Therapeutics accelerates launch of rare cancer drug with analytics-driven insights into its niche market

For Life Sciences

Case Study

Top ten pharma’s oncology brand team uses precision analytics to overhaul their HCP target list for an upcoming drug launch

For Life Sciences

Let’s work together